Article · 27 Feb 2026
ArticlePublished 30 Nov 2024
Comparison of Biologic Agents in the Treatment of Psoriatic Arthritis: A Network Meta-Analysis of Efficacy and Safety
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that often coexists with psoriasis, leading to significant morbidity. The advent of biologic therapies has revolutionized the management of PsA, but the comparative efficacy and safety of different biologic agents remain unclear. This network meta-analysis evaluates data from 25 randomized controlled trials to compare the efficacy and safety profiles of tumor necrosis factor (TNF) inhibitors, interleukin-12/23 inhibitors, and interleukin-17 inhibitors in PsA treatment. The results demonstrate that IL-17 inhibitors have a superior efficacy in achieving minimal disease activity and improving quality of life, while TNF inhibitors remain the most widely used class due to their established safety and efficacy profile.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Clinical Rheumatology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Mia Turner”